Movatterモバイル変換


[0]ホーム

URL:


Eurekaselect logo
Bentham Newsletternewsletter banner
Login
Login

Forgot Your Password? New around here? Sign up
Register Cart 0
Generic placeholder image

Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Editor-in-Chief

ISSN (Print): 1568-0169
ISSN (Online): 1875-6174

Natriuretic Peptide Family: New Aspects

Author(s):Luis Bolanos Cea

Volume 3, Issue 2, 2005

Page: [87 - 98]Pages: 12

DOI:10.2174/1568016053544309

Price: $65

Abstract

Thus far, five molecules comprise the natriuretic peptide family (NPF): ANP, urodilatin, BNP, CNP and DNP. Precursor hormones for ANP, BNP and CNP are encoded by a different gene. Final peptides are ligands for A, B and C receptors, acting the latter as a clearance receptor besides neutral endopeptidase (EC 24.11). cGMP acts as a second messenger. Natriuretic peptides (NP) have well-known functions such as natriuretic, antihypertensive and reduction of plasma renin-aldosterone concentrations. An antiinflammatory ANP potential and a pro-apoptotic action in rats endothelial cells of different NP have been described. Unlike adults, NP show a different distribution during ontogeny and a different pattern of excretion under different stimuli. Noncompetitive immunoassays have become more suitable than competitive ones for routine measurement of NP with recent advances in speed of measurement. BNP and pro-BNP are emerging as useful tools in diagnosis, management and prognosis of heart disease. Preliminary data support a role of NP in the therapy of congestive heart failure. Finally, potential therapeutic compounds of NP in different pathologies are updated with an important focus on vasopeptidase inhibitors. These are capable of strengthening NP and inhibiting renin-angiotensin system at the same time, as potential useful molecules in cardiovascular therapy.

Keywords:natriuretic peptides,anp,urodilatin,bnp,pro-bnp,cnp,dnp,vasopeptidase inhibitors


Rights & PermissionsPrintCite

Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Title: Natriuretic Peptide Family: New Aspects

Volume: 3Issue: 2

Author(s):Luis Bolanos Cea

Affiliation:

    Keywords:natriuretic peptides,anp,urodilatin,bnp,pro-bnp,cnp,dnp,vasopeptidase inhibitors

    Abstract: Thus far, five molecules comprise the natriuretic peptide family (NPF): ANP, urodilatin, BNP, CNP and DNP. Precursor hormones for ANP, BNP and CNP are encoded by a different gene. Final peptides are ligands for A, B and C receptors, acting the latter as a clearance receptor besides neutral endopeptidase (EC 24.11). cGMP acts as a second messenger. Natriuretic peptides (NP) have well-known functions such as natriuretic, antihypertensive and reduction of plasma renin-aldosterone concentrations. An antiinflammatory ANP potential and a pro-apoptotic action in rats endothelial cells of different NP have been described. Unlike adults, NP show a different distribution during ontogeny and a different pattern of excretion under different stimuli. Noncompetitive immunoassays have become more suitable than competitive ones for routine measurement of NP with recent advances in speed of measurement. BNP and pro-BNP are emerging as useful tools in diagnosis, management and prognosis of heart disease. Preliminary data support a role of NP in the therapy of congestive heart failure. Finally, potential therapeutic compounds of NP in different pathologies are updated with an important focus on vasopeptidase inhibitors. These are capable of strengthening NP and inhibiting renin-angiotensin system at the same time, as potential useful molecules in cardiovascular therapy.

    Export Options

    About this article

    Cite this article as:

    Cea Bolanos Luis, Natriuretic Peptide Family: New Aspects, Current Medicinal Chemistry - Cardiovascular & Hematological Agents 2005; 3 (2) .https://dx.doi.org/10.2174/1568016053544309

    DOI
    https://dx.doi.org/10.2174/1568016053544309
    Print ISSN
    1568-0169
    Publisher Name
    Bentham Science Publisher
    Online ISSN
    1875-6174
    Related Journals

    Current Cardiology Reviews

    Cardiovascular & Hematological Agents in Medicinal Chemistry

    Current Hypertension Reviews

    Cardiovascular & Hematological Disorders-Drug Targets

    Current Vascular Pharmacology

    Related Books

    Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease

    Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives

    Frontiers in Clinical Drug Research: Hematology

    Herbal Medicine: Back to the Future

    Cardiac Care and COVID-19: Perspectives in Medical Practice

    Nanomedicinal Approaches Towards Cardiovascular Disease

    Herbal Medicine: Back to the Future

    Article Metrics
    5
    Related Articles
    © 2025 Bentham Science Publishers |Privacy Policy

    [8]ページ先頭

    ©2009-2025 Movatter.jp